{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:53:36Z","timestamp":1770742416445,"version":"3.49.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.farma.2025.03.018","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T15:51:06Z","timestamp":1746460266000},"page":"T212-T217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["[Translated article] Impact of pharmaceutical care on adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia"],"prefix":"10.1016","volume":"49","author":[{"given":"Betel","family":"Del Rosario Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Micaela","family":"Vi\u00f1a Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Gonz\u00e1lez Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Alarc\u00f3n Payer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Oliva Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria Julia","family":"Nazco Casariego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Guti\u00e9rrez Nicol\u00e1s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.farma.2025.03.018_bb0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am J Hematol."},{"issue":"9","key":"10.1016\/j.farma.2025.03.018_bb0010","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjc.6600591","article-title":"Oral cancer treatment: developments in chemotherapy and beyond","volume":"87","author":"O\u2019Neill","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/j.farma.2025.03.018_bb0015","author":"Sociedad Espa\u00f1ola de Farmacia Familiar y Comunitaria (SEFAC)"},{"issue":"3","key":"10.1016\/j.farma.2025.03.018_bb0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1130-6343(06)73968-X","article-title":"Escala simplificada para detectar problemas de adherencia (ESPA) al tratamiento antirretroviral [Simplified scale for medication adherence related problems in anti-retroviral therapy]","volume":"30","author":"Ventura-Cerd\u00e1","year":"2006","journal-title":"Farm Hosp."},{"issue":"7","key":"10.1016\/j.farma.2025.03.018_bb0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ajh.23180","article-title":"Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia","volume":"87","author":"Jabbour","year":"2012","journal-title":"Am J Hematol."},{"issue":"1","key":"10.1016\/j.farma.2025.03.018_bb0030","first-page":"24","article-title":"Adherencia al tratamiento quimioter\u00e1pico oral","volume":"13","author":"Martinez","year":"2011","journal-title":"Atenci\u00f3n Farmace\u00fatica"},{"issue":"14","key":"10.1016\/j.farma.2025.03.018_bb0035","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","article-title":"Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib","volume":"28","author":"Marin","year":"2010","journal-title":"J Clin Oncol."},{"issue":"6","key":"10.1016\/j.farma.2025.03.018_bb0040","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3904\/kjim.2021.158","article-title":"Survival impact of adherence to tyrosine kinase inhibitor in chronic myeloid leukemia","volume":"36","author":"Kim","year":"2021","journal-title":"Korean J Intern Med."},{"key":"10.1016\/j.farma.2025.03.018_bb0045","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.2007.11.5451","article-title":"Adherence to initial adjunvant anastrazole therapy among women with early-stage breast c\u00e1ncer","volume":"26","author":"Partridge","year":"2008","journal-title":"J Clin Oncol."},{"issue":"5","key":"10.1016\/j.farma.2025.03.018_bb0050","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1177\/10781552231196130","article-title":"Risk factors determining adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia","volume":"30","author":"Del Rosario","year":"2024","journal-title":"J Oncol Pharm Pract."},{"issue":"4","key":"10.1016\/j.farma.2025.03.018_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.30827\/ars.v59i4.7357","article-title":"Adherencia terap\u00e9utica: factores modificadores y estrategias de mejora","volume":"59","author":"Pag\u00e8s-Puigdemont","year":"2018","journal-title":"Ars Pharm."},{"issue":"3","key":"10.1016\/j.farma.2025.03.018_bb0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.farma.2024.03.009","article-title":"Atenci\u00f3n farmac\u00e9utica de precisi\u00f3n en oncohematolog\u00eda","volume":"48","author":"Morillo-Verdugo","year":"2024","journal-title":"Farm Hosp."}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634325000431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T23:48:36Z","timestamp":1770680916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634325000431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1130634325000431"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.018","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[Translated article] Impact of pharmaceutical care on adherence to tyrosine kinase inhibitors in chronic myeloid leukaemia","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2025.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2024.11.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}